Table of Contents Table of Contents
Previous Page  7 / 16 Next Page
Basic version Information
Show Menu
Previous Page 7 / 16 Next Page
Page Background

DEBRIDEMENT

slow process of individually picking

off hyperkeratotic scales. The survey

concluded that there was no standard

approach to the management of

hyperkeratosis across Wales. This

led to the development of the first

National Guidance document (Crook

et al, 2014).

The document highlights the

NICE recommendations for the

effectiveness and short procedure

time of using Debrisoft to remove

hyperkeratosis, recommending its

use as part of best practice.

Benefits in the community

Safe and rapid debridement in the

community setting can have many

advantages. A three-week evaluation

of Debrisoft by a group of tissue

viability link nurses found that not

only did Debrisoft achieve ‘timely,

optimal, pain-free removal of non-

viable tissue’, it also helped wound

assessment and thereby treatment

objectives by making the wound

bed more visible, which previously

might have taken weeks to achieve

(Stephen-Haynes and Callaghan,

2012). Furthermore, Callaghan and

Stephen-Haynes (2012) reported

that debriding with Debrisoft

resulted in a definite reduction

in subsequent visits required to

perform an aspect of wound care in

11 out of 12 patients.

Girip and McLoughlin (2013)

stated that safe, rapid and effective

debridement had been limited in

the community for many years

and would normally have required

a specialist nurse referral and a

hospital admission. In a case study,

debridement of the wound and skin

was successfully completed in one

session with Debrisoft, enabling

the patient to remain in her own

home to continue with skin care and

compression therapy. They state that

Debrisoft is an ideal debridement

method for district nurses, enabling

them to perform safe and rapid

debridement at the bedside.

An evaluation of the role of

Debrisoft within the selection of

wound dressings available in the

‘first dressing box’was carried out in

a rural area of North West Wales by

declining workforce, lack of training

and budget cuts, the use of Debrisoft

can play an important part in

assisting the practitioner to instantly

remove soft, non-viable tissue from

the wound bed. Other debridement

methods may take longer to perform

the same task and thus put the

patient at increased risk of wound

infection and delayed healing.

Debrisoft can also be used to

prepare the limb for compression

therapy by quickly removing skin

debris such as dry flakes and

hyperkeratosis, which frequently

two tissue viability nurses. Data from

16 evaluations was analysed and

found that the active debridement

system was a useful addition to the

first dressing initiative. Debrisoft

improved visualisation, which aided

accurate assessment of the wound

bed, and led to reduced debridement

time and quicker progression on

to the next stage of wound healing

(Lloyd-Jones and Parry-Ellis, 2012).

Conclusions

In the current community nursing

climate of increasing caseloads,

An 81-year-old patient presented with a history of venous leg

ulceration and varicose eczema

(Figure 1).

Over a three-year

period the patient suffered from wound deterioration, infection,

severe hyperkeratosis and varicose eczema, resulting in a cycle

of visits to various medical specialists. Despite the support of

the tissue viability nurse, a full holistic leg ulcer assessment,

compression therapy and appropriate treatment, the wound

continued to deteriorate, improve and then deteriorate again

(Figure 2).

The costs associated with the management of this particular wound

and skin condition were considerable. This included 3–4 episodes

of nurse time per week over the three-year period, antibiotics on

a regular basis, hospitalisation, wound dressings and bandages

and various creams such as steroids and emollients. Debrisoft

®

, a

monofilament debridement pad, was used to remove slough

from the wound and hyperkeratosis from the periwound area, to

promote healing.

Debrisoft was used at each clinic visit on five occasions over a two-

week period. Debridement time varied between 2 and 10 minutes and

a positive outcome was noticed immediately on all five occasions. Pain

scores using a visual analogue scale (VAS) were 0 during treatment and

0 after treatment on all five occasions (where 0=no pain).

The wounds and varicose eczema healed following the two weeks of

treatment (

Figure 3

), with compression hosiery being used to maintain

healing. The debridement pad was used twice to prevent the build-up

of hyperkeratosis.

Case report

JCN supplement

2014,Vol 28, No 6

7

Figure 1.

Figure 3.

Figure 2.